Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2188)
All Articles published online
|
Sep 28, 2007 (publication date) through Apr 29, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Semmo N, Klenerman P. CD4+ T cell responses in hepatitis C virus infection. World J Gastroenterol 2007; 13(36): 4831-4838 [PMID: 17828814 DOI: 10.3748/wjg.v13.i36.4831] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v13/i36/4831.htm |
| Number | Citing Articles |
| 1 |
Polyxeni P. Doumba, Elisavet Serti, Maria Boutsikou, Manousos M. Konstadoulakis, Urania Georgopoulou, John Koskinas. Phenotypic and functional alterations of primary human PBMCs induced by HCV non-enveloped capsid-like particles uptake. Cellular and Molecular Life Sciences 2013; 70(18): 3463 doi: 10.1007/s00018-013-1344-y
|
| 2 |
Stefania Farcomeni, Sonia Moretti, Caterina Fimiani, Lucia Fontanelli Sulekova, Fenicia Vescio, Leonardo Sernicola, Maria T. Maggiorella, Anna Lisa Remoli, Orietta Picconi, Luciana Mosca, Rozenn Esvan, Elisa Biliotti, Massimo Ciccozzi, Marco Sgarbanti, Gloria Taliani, Alessandra Borsetti. Short- and Long-Term Immunological Responses in Chronic HCV/HIV Co-Infected Compared to HCV Mono-Infected Patients after DAA Therapy. Pathogens 2021; 10(11): 1488 doi: 10.3390/pathogens10111488
|
| 3 |
Cordelia Manickam, Amanda J. Martinot, Rhianna A. Jones, Valerie Varner, R. Keith Reeves. Hepatic immunopathology during occult hepacivirus re-infection. Virology 2017; 512: 48 doi: 10.1016/j.virol.2017.08.037
|
| 4 |
Elena Removna Chernykh, Ekaterina Alexandrovna Oleynik, Olga Yur’evna Leplina, Natalya Mihaylovna Starostina, Alexander Anatolievich Ostanin. Dendritic cells in the pathogenesis of viral hepatitis C. Russian Journal of Infection and Immunity 2019; 9(2): 239 doi: 10.15789/2220-7619-2019-2-239-252
|
| 5 |
Xinjian Zhang, Jun Dou, Markus W. Germann. Characterization of the cellular immune response in hepatitis C virus infection. Medicinal Research Reviews 2009; 29(6): 843 doi: 10.1002/med.20157
|
| 6 |
Mona M Rafik, Alaa El-Dien MS Hosny, Khaled O Abdallah, Amal A Abbas, Rania A Abo Shady, Dina A Soliman, Khaled M Nasr El-Din Rakha, Shahira F Alfedawy. TH1 cytokine response to HCV peptides in Egyptian health care workers: a pilot study. Virology Journal 2013; 10(1) doi: 10.1186/1743-422X-10-144
|
| 7 |
Mark AA Claassen, Harry LA Janssen, André Boonstra. Role of T cell immunity in hepatitis C virus infections. Current Opinion in Virology 2013; 3(4): 461 doi: 10.1016/j.coviro.2013.05.006
|
| 8 |
Kimia Kardani, Seyed Mehdi Sadat, Mona Kardani, Azam Bolhassani. The next generation of HCV vaccines: a focus on novel adjuvant development. Expert Review of Vaccines 2021; 20(7): 839 doi: 10.1080/14760584.2021.1941895
|
| 9 |
Natalia Echeverría, Victoria Comas, Fabián Aldunate, Paula Perbolianachis, Pilar Moreno, Juan Cristina. In the era of rapid mRNA-based vaccines: Why is there no effective hepatitis C virus vaccine yet? . World Journal of Hepatology 2021; 13(10): 1234-1268 doi: 10.4254/wjh.v13.i10.1234
|
| 10 |
Palma A. Iacovazzi, Raffaele Cozzolongo, Elsa Lanzillotta, Stefania Frisullo, Vito Guerra, Mario Correale. Serum 90K/Mac-2 Binding Protein (Mac-2BP) as a Response Predictor to Peginterferon and Ribavirin Combined Treatment in Hcv Chronic Patients. Immunopharmacology and Immunotoxicology 2008; 30(4): 687 doi: 10.1080/08923970802278177
|
| 11 |
María Q. Marín, Patricia Pérez, Karl Ljungberg, Carlos Óscar S. Sorzano, Carmen E. Gómez, Peter Liljeström, Mariano Esteban, Juan García-Arriaza, J.-H. James Ou. Potent Anti-hepatitis C Virus (HCV) T Cell Immune Responses Induced in Mice Vaccinated with DNA-Launched RNA Replicons and Modified Vaccinia Virus Ankara-HCV. Journal of Virology 2019; 93(7) doi: 10.1128/JVI.00055-19
|
| 12 |
Sumathi Ramachandran, David S. Campo, Zoya E. Dimitrova, Guo-liang Xia, Michael A. Purdy, Yury E. Khudyakov. Temporal Variations in the Hepatitis C Virus Intrahost Population during Chronic Infection. Journal of Virology 2011; 85(13): 6369 doi: 10.1128/JVI.02204-10
|
| 13 |
Sarthak Basak, Arindam Ghosh, Anirban Biswas, Debosmita Bhattacharya, Priti Thakur, Sumana Roy, Saikat Mukherjee, Pronabesh Ghosh, Soubhik Ghosh, Arindam Bhattacharyya. Role and Interrelationship Between Myeloid-Derived Suppressor Cells and CD4+ T Cells in Different Types of Infections: A Review. Proceedings of the Zoological Society 2024; 77(1): 1 doi: 10.1007/s12595-023-00510-4
|
| 14 |
Andre Boonstra, Andrea M. Woltman, Harry L.A. Janssen. Immunology of hepatitis B and hepatitis C virus infections. Best Practice & Research Clinical Gastroenterology 2008; 22(6): 1049 doi: 10.1016/j.bpg.2008.11.015
|
| 15 |
Naglaa H. Shoukry. Hepatitis C Vaccines, Antibodies, and T Cells. Frontiers in Immunology 2018; 9 doi: 10.3389/fimmu.2018.01480
|
| 16 |
Song Chunhui, Chen Liming, Yang Bin, Chi Shuping, Cheng Yun. Seven amino acid peptide mimic from HVR1 of HCV influences cytokine profile of immune cells. Journal of Medical Colleges of PLA 2010; 25(5): 257 doi: 10.1016/S1000-1948(11)60011-7
|
| 17 |
Cinthya Alicia Marcela López, Rosa Nicole Freiberger, Franco Agustín Sviercz, Jorge Quarleri, María Victoria Delpino. HIV-Infected Hepatic Stellate Cells or HCV-Infected Hepatocytes Are Unable to Promote Latency Reversal among HIV-Infected Mononuclear Cells. Pathogens 2024; 13(2): 134 doi: 10.3390/pathogens13020134
|
| 18 |
A. N. Belyavtsev, N. S. Shastina, V. V. Kupriyanov, L. I. Nikolaeva, M. V. Melnikova, E. F. Kolesanova, M. Yu. Shimchishina, I. V. Kapustin. Effect of Lipid Components on Immunogenicity of Synthetic Fragment of Hepatitis C Virus NS4A Antigen. Russian Journal of Bioorganic Chemistry 2022; 48(3): 621 doi: 10.1134/S1068162022030049
|
| 19 |
Daniel M. Andrews, Marie J. Estcourt, Christopher E. Andoniou, Matthew E. Wikstrom, Andrea Khong, Valentina Voigt, Peter Fleming, Hyacinth Tabarias, Geoffrey R. Hill, Robbert G. van der Most, Anthony A. Scalzo, Mark J. Smyth, Mariapia A. Degli-Esposti. Innate immunity defines the capacity of antiviral T cells to limit persistent infection. Journal of Experimental Medicine 2010; 207(6): 1333 doi: 10.1084/jem.20091193
|
| 20 |
Vijayamahantesh Vijayamahantesh, Tapas Patra, Keith Meyer, Mohamad-Gabriel Alameh, Erin K. Reagan, Drew Weissman, Ranjit Ray, J.-H. James Ou. Modified E2 Glycoprotein of Hepatitis C Virus Enhances Proinflammatory Cytokines and Protective Immune Response. Journal of Virology 2022; 96(12) doi: 10.1128/jvi.00523-22
|
| 21 |
Helal F. Hetta, Asmaa M. Zahran, Shima G. Mansor, Mohamed O. Abdel‐Malek, Mohamed A. Mekky, Wael A. Abbas. Frequency and Implications of myeloid‐derived suppressor cells and lymphocyte subsets in Egyptian patients with hepatitis C virus‐related hepatocellular carcinoma. Journal of Medical Virology 2019; 91(7): 1319 doi: 10.1002/jmv.25428
|
| 22 |
Joey McGregor, Joshua M. Hardy, Chan-Sien Lay, Irene Boo, Michael Piontek, Manfred Suckow, Fasséli Coulibaly, Pantelis Poumbourios, Rob J. Center, Heidi E. Drummer, J.-H. James Ou. Virus-Like Particles Containing the E2 Core Domain of Hepatitis C Virus Generate Broadly Neutralizing Antibodies in Guinea Pigs. Journal of Virology 2022; 96(5) doi: 10.1128/jvi.01675-21
|
| 23 |
Julian Schulze zur Wiesch, Donatella Ciuffreda, Lia Lewis-Ximenez, Victoria Kasprowicz, Brian E. Nolan, Hendrik Streeck, Jasneet Aneja, Laura L. Reyor, Todd M. Allen, Ansgar W. Lohse, Barbara McGovern, Raymond T. Chung, William W. Kwok, Arthur Y. Kim, Georg M. Lauer. Broadly directed virus-specific CD4+ T cell responses are primed during acute hepatitis C infection, but rapidly disappear from human blood with viral persistence. Journal of Experimental Medicine 2012; 209(1): 61 doi: 10.1084/jem.20100388
|
| 24 |
Rosalyn Casey, Deena Blumenkrantz, Kerry Millington, Damien Montamat-Sicotte, Onn Min Kon, Melissa Wickremasinghe, Samuel Bremang, Murphy Magtoto, Saranya Sridhar, David Connell, Ajit Lalvani, Denise L. Doolan. Enumeration of Functional T-Cell Subsets by Fluorescence-Immunospot Defines Signatures of Pathogen Burden in Tuberculosis. PLoS ONE 2010; 5(12): e15619 doi: 10.1371/journal.pone.0015619
|
| 25 |
E. John Wherry, Paul Klenerman. The Immune Response to Infection. 2014; : 255 doi: 10.1128/9781555816872.ch20
|
| 26 |
Isabela S. Oliveira, Lucas P. Carvalho, Maria Isabel Schinoni, Raymundo Paraná, Ajax M. Atta, Maria Luiza B. Sousa Atta. Peripheral lymphocyte subsets in chronic hepatitis C: Effects of 12 weeks of antiviral treatment with interferon-alpha plus ribavirin. Microbial Pathogenesis 2016; 91: 155 doi: 10.1016/j.micpath.2015.12.007
|
| 27 |
L. Alvarez‐Lajonchere, N. H. Shoukry, B. Grá, Y. Amador‐Cañizares, F. Helle, N. Bédard, I. Guerra, C. Drouin, J. Dubuisson, E. E. González‐Horta, G. Martínez, J. Marante, Z. Cinza, M. Castellanos, S. Dueñas‐Carrera. Immunogenicity of CIGB‐230, a therapeutic DNA vaccine preparation, in HCV‐chronically infected individuals in a Phase I clinical trial. Journal of Viral Hepatitis 2009; 16(3): 156 doi: 10.1111/j.1365-2893.2008.01058.x
|
| 28 |
Mohamed Abdel‐Samiee, Mohamed I. Youssef, Fathy Elghamry, Mahmoud Bazeed, Mohamed Al‐Shorbagy, Helmy Shalaby, Hossam Shabana, Eman Abdelsameea, Hesham El Sayed Lashin, Hossam M. Farid El Zamek, Tarek Esam, Mohammad AbdElhameed Ahmed Alwaseef, Housam Ahmed Helmy, Feras Almarshad, Fatma A. Khalaf, Badawy W. AboBakr Yossef, Arafat Kassem, Basant Mostafa Gabr, Ahmed Abdelfattah, Hind S. AboShabaan, Galal Abdelhameed Aboufarrag, Marwa M. Omar, Mohammed Saied Bakeer, Mohammed S. Imam, Essam S. Ibrahim, Shimaa Y Kamel, Talaat Allisy, Omima Sayed Mohammed, Ali Farahat, Mohsen M. El‐Khayat, Mohamed Abdelrafaa Hassan Sekeen, Eman Mohammed Zaher, Ashraf Said, Ahmed Abuamer, Essam Elmahdi. A multicentric and nationwide predictive study role of T cell sub‐population in the prevalence and prognosis of cryoglobulinemia among genotype 4 chronic hepatitis C patients. Journal of Medical Virology 2023; 95(12) doi: 10.1002/jmv.29248
|
| 29 |
Kyung Hee Kang, Yasuhiro Yamamura, Maria P. Carlos, Nicolas Karvelas, In-Sup Kim, Deepa Sunkara, Rebecca Rivera, Murray B. Gardner, David E. Anderson, Francisco Diaz-Mitoma, José V. Torres, Juan P. Marquez. Synthetic Antigens Representing the Antigenic Variation of Human Hepatitis C Virus. Viral Immunology 2010; 23(5): 497 doi: 10.1089/vim.2010.0043
|
| 30 |
Timothy T. Spear, Glenda G. Callender, Jeffrey J. Roszkowski, Kelly M. Moxley, Patricia E. Simms, Kendra C. Foley, David C. Murray, Gina M. Scurti, Mingli Li, Justin T. Thomas, Alexander Langerman, Elizabeth Garrett-Mayer, Yi Zhang, Michael I. Nishimura. TCR gene-modified T cells can efficiently treat established hepatitis C-associated hepatocellular carcinoma tumors. Cancer Immunology, Immunotherapy 2016; 65(3): 293 doi: 10.1007/s00262-016-1800-2
|
| 31 |
Michael A. Nalesnik, Tatsuya Kanto. Natural Killer Cells. 2010; : 571 doi: 10.1016/B978-0-12-370454-2.00044-2
|
| 32 |
Paul Shapshak, Charurut Somboonwit, Lydia N. Drumright, Simon D.W. Frost, Deborah Commins, Timothy L. Tellinghuisen, William K. Scott, Robert Duncan, Clyde McCoy, J. Bryan Page, Brian Giunta, Francisco Fernandez, Elyse Singer, Andrew Levine, Alireza Minagar, Oluwadayo Oluwadara, Taiwo Kotila, Francesco Chiappelli, John T. Sinnott. Molecular and Contextual Markers of Hepatitis C Virus and Drug Abuse. Molecular Diagnosis & Therapy 2009; 13(3): 153 doi: 10.1007/BF03256323
|
| 33 |
Samaa T. Gobran, Petronela Ancuta, Naglaa H. Shoukry. A Tale of Two Viruses: Immunological Insights Into HCV/HIV Coinfection. Frontiers in Immunology 2021; 12 doi: 10.3389/fimmu.2021.726419
|
| 34 |
KASHIF ASGHAR, M. TAIMOUR ASHIQ, BILAL ZULFIQAR, AMNAH MAHROO, KAENAT NASIR, SHEEBA MURAD. Indoleamine 2,3-dioxygenase expression and activity in patients with hepatitis C virus-induced liver cirrhosis. Experimental and Therapeutic Medicine 2015; 9(3): 901 doi: 10.3892/etm.2014.2146
|
| 35 |
Naglaa H. Shoukry. Towards a Systems Immunology Approach to Understanding Correlates of Protective Immunity against HCV. Viruses 2021; 13(9): 1871 doi: 10.3390/v13091871
|
| 36 |
Michaela Lucas, Pooja Deshpande, Ian James, Andri Rauch, Katja Pfafferott, Elouise Gaylard, Shahzma Merani, Anne Plauzolles, Andrew Lucas, Wyatt McDonnell, Spyros Kalams, Mark Pilkinton, Cody Chastain, Louise Barnett, Amy Prosser, Simon Mallal, Karen Fitzmaurice, Heidi Drummer, M. Azim Ansari, Vincent Pedergnana, Ellie Barnes, Mina John, Dermot Kelleher, Paul Klenerman, Silvana Gaudieri. Evidence of CD4+ T cell-mediated immune pressure on the Hepatitis C virus genome. Scientific Reports 2018; 8(1) doi: 10.1038/s41598-018-25559-6
|
| 37 |
H. J. Hartling, J. C. Gaardbo, A. Ronit, M. Salem, M. Laye, M. R. Clausen, K. Skogstrand, J. Gerstoft, H. Ullum, S. D. Nielsen. Impaired Thymic Output in Patients with Chronic Hepatitis C Virus Infection. Scandinavian Journal of Immunology 2013; 78(4): 378 doi: 10.1111/sji.12096
|
| 38 |
Arshi Khanam, Shyamasundaran Kottilil, Eleanor Wilson. Reconstitution of T follicular helper-humoral immune axis with elimination of hepatitis C virus. Scientific Reports 2020; 10(1) doi: 10.1038/s41598-020-77020-2
|
| 39 |
J. F. Möller, B. Möller, B. Wiedenmann, T. Berg, E. Schott. CD154, a marker of antigen‐specific stimulation of CD4 T cells, is associated with response to treatment in patients with chronic HCV infection. Journal of Viral Hepatitis 2011; 18(7) doi: 10.1111/j.1365-2893.2010.01430.x
|
| 40 |
Xiufeng Wang, Yunqing Zhong, Rongzhen Zhang, Yueqiao Chen, Minggang Wang, Chao Lv, Dewen Mao, Ruchika Garg. Wenyang Huazhuo Tuihuang Formula Inhibits the Th17/Treg Cell Imbalance and Protects against Acute-on-Chronic Liver Failure. Evidence-Based Complementary and Alternative Medicine 2022; 2022: 1 doi: 10.1155/2022/5652172
|
| 41 |
Joshua D. Duncan, Richard A. Urbanowicz, Alexander W. Tarr, Jonathan K. Ball. Hepatitis C Virus Vaccine: Challenges and Prospects. Vaccines 2020; 8(1): 90 doi: 10.3390/vaccines8010090
|
| 42 |
Yan Zhou, Benoît Callendret, Dan Xu, Kathleen M. Brasky, Zongdi Feng, Lucinda L. Hensley, Jeremie Guedj, Alan S. Perelson, Stanley M. Lemon, Robert E. Lanford, Christopher M. Walker. Dominance of the CD4+ T helper cell response during acute resolving hepatitis A virus infection. Journal of Experimental Medicine 2012; 209(8): 1481 doi: 10.1084/jem.20111906
|
| 43 |
M. Bes, S. Sauleda, N. Casamitjana, M. Piron, I. Campos‐Varela, J. Quer, M. Cubero, L. Puig, J. Guardia, J. I. Esteban. Reversal of nonstructural protein 3‐specific CD4+ T cell dysfunction in patients with persistent hepatitis C virus infection. Journal of Viral Hepatitis 2012; 19(4): 283 doi: 10.1111/j.1365-2893.2011.01549.x
|
| 44 |
Justyna Kaźmierczak, Kamila Caraballo Cortes, Iwona Bukowska-Ośko, Marek Radkowski. Virus-Specific Cellular Response in Hepatitis C Virus Infection. Archivum Immunologiae et Therapiae Experimentalis 2016; 64(2): 101 doi: 10.1007/s00005-015-0364-8
|
| 45 |
Elisavet Serti, Polyxeni P. Doumba, George Thyphronitis, Panagiota Tsitoura, Konstantina Katsarou, Pelagia Foka, Manousos M. Konstandoulakis, John Koskinas, Penelope Mavromara, Urania Georgopoulou. Modulation of IL-2 expression after uptake of hepatitis C virus non-enveloped capsid-like particles: the role of p38 kinase. Cellular and Molecular Life Sciences 2011; 68(3): 505 doi: 10.1007/s00018-010-0466-8
|
| 46 |
H.I. Basha, V. Subramanian, A. Seetharam, D.S. Nath, S. Ramachandran, C.D. Anderson, S. Shenoy, W.C. Chapman, J.S. Crippin, T. Mohanakumar. Characterization of HCV-Specific CD4+Th17 Immunity in Recurrent Hepatitis C–Induced Liver Allograft Fibrosis. American Journal of Transplantation 2011; 11(4): 775 doi: 10.1111/j.1600-6143.2011.03458.x
|